• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患者呼吸系统健康的社会经济决定因素:对治疗策略的影响。

Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.

机构信息

Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Division of Pulmonary Medicine, Department of Pediatrics, Virginia Commonwealth University and Children's Hospital of Richmond at VCU, USA.

出版信息

Expert Rev Respir Med. 2022 Jun;16(6):637-650. doi: 10.1080/17476348.2022.2090928. Epub 2022 Jun 23.

DOI:10.1080/17476348.2022.2090928
PMID:35705523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9329222/
Abstract

INTRODUCTION

Great variation exists in the progression and outcomes of cystic fibrosis (CF) lung disease, due to both genetic and environmental influences. Social determinants mediate environmental exposures and treatment success; people with CF from socioeconomically disadvantaged backgrounds have worse health and die younger than those in more advantaged positions.

AREAS COVERED

This paper reviews the literature on the mechanisms that are responsible for generating and sustaining disparities in CF health, and the ways by which social determinants translate into health advantages or disadvantages in people with CF. The authors make recommendations for addressing social risk factors in CF clinical practice.

EXPERT OPINION

Socioeconomic factors are not dichotomous and their impact is felt at every step of the social ladder. CF care programs need to adopt a systematic protocol to screen for health-related social risk factors, and then connect patients to available resources to meet individual needs. Considerations such as daycare, schooling options, living and working conditions, and opportunities for physical exercise and recreation as well as promotion of self-efficacy are often overlooked. In addition, advocacy for changes in public policies on health insurance, environmental regulations, social welfare, and education would all help address the root causes of CF health inequities.

摘要

简介

囊性纤维化(CF)肺部疾病的进展和结果存在很大差异,这是由于遗传和环境因素的共同作用。社会决定因素调节环境暴露和治疗效果;来自社会经济地位较低背景的 CF 患者的健康状况较差,比处于较有利地位的患者更早死亡。

涵盖领域

本文回顾了导致 CF 健康差异的机制的文献,以及社会决定因素如何在 CF 患者中转化为健康优势或劣势。作者为 CF 临床实践中解决社会风险因素提出了建议。

专家意见

社会经济因素并非非此即彼,其影响在社会阶梯的每一步都能感受到。CF 护理项目需要采用系统方案来筛选与健康相关的社会风险因素,然后将患者与可用资源联系起来,以满足个人需求。诸如日托、学校选择、生活和工作条件以及体育锻炼和娱乐机会以及自我效能的提升等方面往往被忽视。此外,倡导医疗保险、环境法规、社会福利和教育方面的公共政策改革将有助于解决 CF 健康不平等的根本原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2518/9329222/0e7cfd8b2836/nihms-1818323-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2518/9329222/0e7cfd8b2836/nihms-1818323-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2518/9329222/0e7cfd8b2836/nihms-1818323-f0001.jpg

相似文献

1
Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.囊性纤维化患者呼吸系统健康的社会经济决定因素:对治疗策略的影响。
Expert Rev Respir Med. 2022 Jun;16(6):637-650. doi: 10.1080/17476348.2022.2090928. Epub 2022 Jun 23.
2
Socioeconomic status and health outcomes: cystic fibrosis as a model.社会经济地位与健康结果:以囊性纤维化为例
Expert Rev Respir Med. 2016 Sep;10(9):967-77. doi: 10.1080/17476348.2016.1196140. Epub 2016 Jun 9.
3
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
4
Aiming to Improve Equity in Pulmonary Health: Cystic Fibrosis.旨在改善肺部健康公平性:囊性纤维化。
Clin Chest Med. 2023 Sep;44(3):555-573. doi: 10.1016/j.ccm.2023.03.011. Epub 2023 May 8.
5
Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.囊性纤维化的基因检测。美国国立卫生研究院关于囊性纤维化基因检测的共识发展会议声明。
Arch Intern Med. 1999 Jul 26;159(14):1529-39.
6
Influences of environmental exposures on individuals living with cystic fibrosis.环境暴露对囊性纤维化患者的影响。
Expert Rev Respir Med. 2020 Jul;14(7):737-748. doi: 10.1080/17476348.2020.1753507. Epub 2020 Apr 26.
7
[Italian Cystic Fibrosis Register - Report 2010].[意大利囊性纤维化登记处——2010年报告]
Epidemiol Prev. 2016 Mar-Apr;40(2 Suppl 2):1-47. doi: 10.19191/EP16.2S2.P001.074.
8
Nongenetic influences on cystic fibrosis outcomes.非遗传因素对囊性纤维化结局的影响。
Curr Opin Pulm Med. 2011 Nov;17(6):448-54. doi: 10.1097/MCP.0b013e32834ba899.
9
Exercise as a therapeutic intervention for people with cystic fibrosis.运动作为囊性纤维化患者的一种治疗干预手段。
Expert Rev Respir Med. 2019 May;13(5):449-458. doi: 10.1080/17476348.2019.1598861. Epub 2019 Mar 29.
10
Physiotherapy in cystic fibrosis: optimising techniques to improve outcomes.囊性纤维化的物理疗法:优化技术以改善结果。
Paediatr Respir Rev. 2013 Dec;14(4):263-9. doi: 10.1016/j.prrv.2012.08.006. Epub 2012 Nov 4.

引用本文的文献

1
Methicillin-resistant and pulmonary outcome in people with cystic fibrosis: a European Cystic Fibrosis Patient Registry data analysis.囊性纤维化患者的耐甲氧西林情况与肺部转归:一项欧洲囊性纤维化患者注册数据库数据分析
ERJ Open Res. 2025 Sep 1;11(5). doi: 10.1183/23120541.01284-2024. eCollection 2025 Sep.
2
Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis.囊性纤维化患者的社会经济地位与药物依从性之间的关联
Pediatr Pulmonol. 2025 Aug;60(8):e71230. doi: 10.1002/ppul.71230.
3
Predictors of frequency of CF care in the US Cystic Fibrosis Foundation Patient Registry.

本文引用的文献

1
Cessation of smoke exposure improves pediatric CF outcomes: Longitudinal analysis of CF Foundation Patient Registry data.停止吸烟暴露可改善儿童 CF 结局:CF 基金会患者登记数据的纵向分析。
J Cyst Fibros. 2021 Jul;20(4):618-624. doi: 10.1016/j.jcf.2021.06.014. Epub 2021 Jul 17.
2
Association between insurance variability and early lung function in children with cystic fibrosis.保险变化与囊性纤维化患儿早期肺功能的关系。
J Cyst Fibros. 2022 Jan;21(1):104-110. doi: 10.1016/j.jcf.2021.06.006. Epub 2021 Jun 24.
3
Speaking of pandemics..
美国囊性纤维化基金会患者登记处中CF护理频率的预测因素。
PLoS One. 2024 Dec 3;19(12):e0313510. doi: 10.1371/journal.pone.0313510. eCollection 2024.
说到大流行病……
J Cyst Fibros. 2021 Jul;20(4):564-565. doi: 10.1016/j.jcf.2021.04.017. Epub 2021 Jun 5.
4
Racial Segregation and Respiratory Outcomes among Urban Black Residents with and at Risk of Chronic Obstructive Pulmonary Disease.患有慢性阻塞性肺疾病及有患病风险的城市黑人居民中的种族隔离与呼吸结局
Am J Respir Crit Care Med. 2021 Sep 1;204(5):536-545. doi: 10.1164/rccm.202009-3721OC.
5
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study.欧洲囊性纤维化患者的生存估计及其社会经济因素的影响:一项回顾性登记队列研究。
Eur Respir J. 2021 Oct 1;58(3). doi: 10.1183/13993003.02288-2020. Print 2021 Sep.
6
Disparities in cystic fibrosis survival in Mexico: Impact of socioeconomic status.墨西哥囊性纤维化存活率的差异:社会经济地位的影响。
Pediatr Pulmonol. 2021 Jun;56(6):1566-1572. doi: 10.1002/ppul.25351. Epub 2021 Mar 13.
7
The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States.美国地区贫困状况和州儿童健康状况与囊性纤维化儿科患者呼吸系统结局的相关性。
Pediatr Pulmonol. 2021 May;56(5):883-890. doi: 10.1002/ppul.25192. Epub 2020 Dec 14.
8
Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosis.烟草烟雾暴露限制了泰它西普/依伐卡托在儿科囊性纤维化患者中的治疗获益。
J Cyst Fibros. 2021 Jul;20(4):612-617. doi: 10.1016/j.jcf.2020.09.011. Epub 2020 Oct 3.
9
Patterns of Health Insurance Coverage and Lung Disease Progression in Adolescents and Young Adults with Cystic Fibrosis.青少年和年轻成人囊性纤维化患者的健康保险覆盖模式与肺部疾病进展。
Ann Am Thorac Soc. 2021 Feb;18(2):290-299. doi: 10.1513/AnnalsATS.201911-839OC.
10
Decreased survival in cystic fibrosis patients with a positive screen for depression.囊性纤维化患者抑郁筛查阳性者生存率降低。
J Cyst Fibros. 2021 Jan;20(1):120-126. doi: 10.1016/j.jcf.2020.07.020. Epub 2020 Aug 13.